Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.40 -0.31 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Interest & Investment Income (2016 - 2026)

Updated

Madrigal Pharmaceuticals (MDGL) posted Interest & Investment Income of $7.1 million for Q2 2026, down 13.7% from $8.23 million a year earlier and down 13.8% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Interest & Investment Income (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Madrigal Pharmaceuticals was $35.11 million, down 15.8% year-over-year; for FY2025, it came in at $37.36 million, down 19.9% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 53.9% (FY2020 to FY2025).
  • In prior years, Madrigal Pharmaceuticals' Interest & Investment Income was $46.65 million in FY2024 (+138.3%), $19.58 million in FY2023 (+796.0%), $2.19 million in FY2022 (+501.9%) and $363,000 in FY2021 (-91.6%).
  • The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q3 2023.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last five quarters, with growth averaging 28.5% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 999.4%; the weakest was Q3 2021, with a decline of 92.7%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $8.24 million (Q1 2026), $9.46 million (Q4 2025) and $10.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Madrigal Pharmaceuticals 14.56 Bn 10.81 Bn - 7.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.10 Mn
Mar 31, 2026 8.24 Mn
Dec 31, 2025 9.46 Mn
Sep 30, 2025 10.31 Mn
Jun 30, 2025 8.23 Mn
Mar 31, 2025 9.37 Mn
Dec 31, 2024 11.08 Mn
Sep 30, 2024 13.02 Mn
Jun 30, 2024 14.22 Mn
Mar 31, 2024 8.33 Mn
Dec 31, 2023 8.95 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 3.55 Mn
Mar 31, 2023 3.78 Mn
Dec 31, 2022 1.08 Mn
Sep 30, 2022 717,000.00
Jun 30, 2022 323,000.00
Mar 31, 2022 69,000.00
Dec 31, 2021 52,000.00
Sep 30, 2021 60,000.00
API Access

Madrigal Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MDGL&period=max&api_key=YOUR_API_KEY